Infectious Disease Control

ARIA Study Shows Superior Efficacy of Triumeq(R) for Treatment-naive Women Living with HIV

LONDON, England and DURBAN, South Africa, July 18, 2016 /PRNewswire/ -- ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq® (dolutegravir/abacavir/lamivudine) compared with atazanavir boos...

2016-07-18 20:29 2244

RayVio Deep UV LEDs Show Strong Disinfection Performance in Test

HAYWARD, California, July 7, 2016 /PRNewswire/ -- RayVio Corp. , an advanced health and hygiene company, today announced study results from efficacy testing of its deep ultraviolet (UV) LED solution for disinfection. The study shows that RayVio's deep UV LEDs can eliminat...

2016-07-07 08:00 2287

KT CEO Hwang Chang-Gyu Delivers Speech at UN Global Compact: "Join hands with the UN to prevent the spread of global diseases"

SEOUL, South Korea, June 27, 2016 /PRNewswire/ -- KT CEO Hwang Chang-gyu delivered a speech to officials from the UN and global telecom companies, proposing to cooperate to contain infectious diseases by using big data solution. KT is planning to release its big data analysis algorithm related to co...

2016-06-27 22:27 1790

Sanofi Pasteur Dengue Vaccine Approved in Costa Rica

SAN JOSE, Costa Rica, June 23, 2016 /PRNewswire/ -- Today Sanofi Pasteur, Sanofi's vaccine division, announced that the National Ministry of Health ofCosta Rica has approved Sanofi Pasteur's tetravalent dengue vaccine, Dengvaxia®, to protect individuals 9 to 45 years of age living in endemic area...

2016-06-23 11:05 2575

FDA Approves PaxVax to Manufacture Vaxchora™ (Oral Cholera Vaccine) at SynCo Bio Partners

AMSTERDAM, June 20, 2016 /PRNewswire/ -- SynCo Bio Partners, a world leading GMP contract manufacturer of biopharmaceuticals, today announced that one of its customers, PaxVax, has received FDA approval for Vaxchora™, a single-dose oral, live attenuated cholera vaccine, indicated for use in adu...

2016-06-20 15:00 2583

ADVA launches Dengue Mission Buzz Barometer tool to boost critical dengue prevention awareness and preparedness amongst ASEAN Community

SINGAPORE, June 15, 2016 /PRNewswire/ -- In support of the 6th Association of Southeast Asian Nations (ASEAN) Dengue Day, the Asian Dengue Vaccination Advocacy (ADVA) is launching the Dengue Mission Buzz Barometer, a tool to measure ASEAN community engagement for the prevention of dengue. The Bar...

2016-06-15 10:00 2365

Innovative Diagnostics Awarded Unprecedented Westgard Sigma Certification in Singapore

SINGAPORE, June 8, 2016 /PRNewswire/ -- Putting patients at the heart of what they do - Innovative Diagnostics, a leading private pathology provider in Singapore, has received the Westgard Sigma certification, becoming the first medical institution inSingapore to be recognized by the Westgard Sigm...

2016-06-08 09:00 3424

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

NANJING, China, June 6, 2016 /PRNewswire/ -- Frontier Biotechnologies Inc. today reported that a phase 3 clinical trial (TALENT Study) of its lead product albuvirtide meets primary objective based on an interim analysis. The results demonstrated that once-weekly given albuvirtide plus ritonavir-b...

2016-06-06 14:03 2306

Ennaid Therapeutics Invited To Participate In The International Society for Neglected Tropical Diseases: Discovery, Development, Diagnostics (ISNTD d3) Conference In London, UK

ALPHARETTA, Ga., May 24, 2016 /PRNewswire/ -- The President and CEO of Ennaid Therapeutics,Darnisha Harrison, will be speaking at the 2016 ISNTD d3 conference. The conference will take place onMay 25th and 26th in London, United Kingdom and will address the drug discovery, development and diagnos...

2016-05-24 01:34 1756

Strategic Advisory Group of Experts on Immunization Convened by the World Health Organization Recommends Use of Sanofi Pasteur's Dengue Vaccine in Endemic Countries

SINGAPORE, April 15, 2016 /PRNewswire/ --Sanofi (EURONEXT: SAN), (NYSE: SNY) and its vaccines global business unitSanofi Pasteur , announced today that the Strategic Advisory Group of Experts on Immunization (SAGE) has issued it...

2016-04-15 19:22 3207

First Dengue Vaccine, Dengvaxia(R), Awarded 'The Vaccine Breakthrough of 2016' At the 6th Annual Biopharma Industry Awards Event In Singapore

SINGAPORE, March 28, 2016 /PRNewswire/ -- Sanofi Pasteur , the vaccines division of Sanofi , is pleased to announce the company's dengue vaccine, Dengvaxia®, received the award for "The Vaccine Breakthrough of 2016" at the 6th an...

2016-03-28 09:00 3518

BioNet-Asia Announces the Formation of its Scientific Advisory Board

PARIS, March 21, 2016 /PRNewswire/ -- BioNet-Asia, an innovative clinical stage vaccine company, announced the formation of BioNet Scientific Advisory Board (SAB), under the chairmanship of Emeritus Prof. Dr.Stanley Plotkin. The mission of BioNet SAB will be to provide valuable scientific advice,...

2016-03-21 22:03 2106

BETADINE(R) Leads the Fight Against Hand Foot and Mouth Disease (HFMD) Infection

SINGAPORE, March 15, 2016 /PRNewswire/ -- New research has highlighted the effectiveness ofBETADINE® products in the fight against Hand Foot and Mouth Disease (HFMD), a viral infection that affects thousands of young children each year. There is a high incidence of HFMD in Asia. The World Health...

2016-03-15 11:03 2164

HSRx Biopharmaceutical and Thorne Research in Collaboration for Botanical Drug Development

TUCSON, Ariz., March 3, 2016 /PRNewswire/ -- HSRx Biopharmaceutical , a leading developer of polyfunctional-powered combination drugs for infectious disease conditions and disease conditions related to aging and lifestyle, andThorne Research

2016-03-03 23:00 4196

Expert coalition announces region's first call-to-action charter urging prioritization of dengue efforts to combat disease burden

BANGKOK, Thailand, Feb. 25, 2016 /PRNewswire/ -- Leading experts state that urgent action is needed to combat dengue inAsia following the inaugural Asia Dengue Summit in January this year. Key stakeholders comprising leading regional clinicians, researchers, public health leaders, government offi...

2016-02-25 14:00 2245

Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

NEW BRUNSWICK, N.J., Feb. 17, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) todayissued a call for innovative ideas as part of the DREAMS Innovation Challenge, which is supported by the U.S. President's Emergency Plan for AI...

2016-02-17 22:00 3012

SC Johnson Announces $15 Million Donation to Help Protect Families Around the World from Mosquito-Borne Diseases such as Zika

RACINE, Wisconsin, Feb. 17, 2016 /PRNewswire/ -- Today, given the rising global outbreak of Zika, SC Johnson announced it will donate at least$15 million over the next year to provide products to help needy families combat the mosquitoes that may carry the disease. As the world's leading manufact...

2016-02-17 04:56 2722

Expansion of Oxitec's Vector Control Solution in Brazil Attacking Source of Zika Virus and Dengue Fever after Positive Program Results

OXFORD, England and GERMANTOWN, Md., Jan. 19, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its subsidiary Oxitec and Piracicaba City Hall have expanded the 'FriendlyAedes aegypti Project' in Piracicaba, Brazil followin...

2016-01-19 20:00 2111

Regional Coalition Calls on Governments in Asia to Support Collaborative Efforts to Combat Growing Dengue Threat

SINGAPORE, Jan. 12, 2016 /PRNewswire/ -- On the heels of Asia's first dengue vaccine approval inthe Philippines, the inaugural Asian Dengue Summit opening in Bangkok on January 13 is making a rallying call to governments and health authorities inAsia to collaborate and integrate regi...

2016-01-12 11:56 2907

Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant

BEIJING, Jan. 4, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of vaccine products, today announced positive topline results from Phase I clinical trial of PIKA rabies vacci...

2016-01-04 09:00 3101
1 ... 35363738394041 ... 45